New hope for tough schizophrenia cases? phase 3 trial launches
Symptom relief
Recruiting now
This study tests whether a new drug called evenamide can help people with treatment-resistant schizophrenia whose symptoms are not well controlled by their current antipsychotic medication. About 400 adults will receive either evenamide or a placebo added to their usual treatment…
Phase: PHASE3 • Sponsor: Newron Pharmaceuticals SPA • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC